Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach. (2023)
Attributed to:
MICA: Molecular drivers of fibrosis at the hepatic epithelial-mesenchymal barrier
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41575-023-00796-x
PubMed Identifier: 37268740
Publication URI: http://europepmc.org/abstract/MED/37268740
Type: Journal Article/Review
Volume: 20
Parent Publication: Nature reviews. Gastroenterology & hepatology
Issue: 10
ISSN: 1759-5045